BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 25131134)

  • 1. New-onset diabetes mellitus and the analysis of dipeptidyl-peptidase-4 after liver transplantation.
    Gámán G; Sárváry E; Gelley F; Doros A; Görög D; Fehérvári I; Kóbori L; Wágner L; Nemes B
    Transplant Proc; 2014; 46(6):2177-80. PubMed ID: 25131134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Incretin Hormones After Orthotopic Liver Transplantation.
    Gámán G; Sárváry E; Gelley F; Doros A; Görög D; Fehérvári I; Kóbori L; Wágner L; Máthé Z; Nemes B
    Transplant Proc; 2015 Sep; 47(7):2207-9. PubMed ID: 26361681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 5-time point oral glucose tolerance test as a predictor of new-onset diabetes after kidney transplantation.
    Tokodai K; Amada N; Haga I; Takayama T; Nakamura A
    Diabetes Res Clin Pract; 2014 Feb; 103(2):298-303. PubMed ID: 24468096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum dipeptidyl peptidase-4 activity in insulin resistant patients with non-alcoholic fatty liver disease: a novel liver disease biomarker.
    Firneisz G; Varga T; Lengyel G; Fehér J; Ghyczy D; Wichmann B; Selmeci L; Tulassay Z; Rácz K; Somogyi A
    PLoS One; 2010 Aug; 5(8):e12226. PubMed ID: 20805868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Levels of Osteocalcin and Insulin Resistance in Patients with Impaired Glucose Tolerance or New-Onset Diabetes Mellitus After Liver Transplantation.
    Martínez-Díaz-Guerra G; Guadalix S; Aramendi M; Librizzi S; García E; Jiménez C; Hawkins F
    Horm Metab Res; 2016 May; 48(5):325-30. PubMed ID: 26743527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in glucose metabolism associated with liver cirrhosis persist in the clinically stable long-term course after liver transplantation.
    Tietge UJ; Selberg O; Kreter A; Bahr MJ; Pirlich M; Burchert W; Müller MJ; Manns MP; Böker KH
    Liver Transpl; 2004 Aug; 10(8):1030-40. PubMed ID: 15390330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of β-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: Role of severity of liver disease.
    Grancini V; Trombetta M; Lunati ME; Zimbalatti D; Boselli ML; Gatti S; Donato MF; Resi V; D'Ambrosio R; Aghemo A; Pugliese G; Bonadonna RC; Orsi E
    J Hepatol; 2015 Dec; 63(6):1484-90. PubMed ID: 26297917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes pattern on the 75 g oral glucose tolerance test is a risk factor for hepatocellular carcinoma in patients with hepatitis C virus.
    Konishi I; Hiasa Y; Shigematsu S; Hirooka M; Furukawa S; Abe M; Matsuura B; Michitaka K; Horiike N; Onji M
    Liver Int; 2009 Sep; 29(8):1194-201. PubMed ID: 19422477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of hyperglycemic clamp technique in the assessment of beta-cell function in obese individuals with glucose intolerance].
    Bao YQ; Jia WP; Zhu M; Lu JX; Chen L; Xiang KS
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1781-4. PubMed ID: 15631773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance and insulin secretion in renal transplant recipients with hepatitis C.
    Uchida J; Iwai T; Machida Y; Kuwabara N; Kabei K; Kumada N; Nakatani T
    Transplant Proc; 2013 May; 45(4):1540-3. PubMed ID: 23726615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Insulin Resistance and β-Cell Dysfunction Between the Young and the Elderly in Normal Glucose Tolerance and Prediabetes Population: A Prospective Study.
    Chen G; Shi L; Cai L; Lin W; Huang H; Liang J; Li L; Lin L; Tang K; Chen L; Lu J; Bi Y; Wang W; Ning G; Wen J
    Horm Metab Res; 2017 Feb; 49(2):135-141. PubMed ID: 27459384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
    Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
    Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: An underdiagnosed phenomenon.
    Sharif A; Moore RH; Baboolal K
    Transplantation; 2006 Dec; 82(12):1667-72. PubMed ID: 17198257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic characteristics of subjects with normal glucose tolerance and 1-h hyperglycaemia.
    Qian L; Fu X; Xu L; Zheng S; Zhou W; Wang X; Gu Y; Lin F; Luo M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):575-9. PubMed ID: 18248638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between insulin resistance and left ventricular diastolic dysfunction in patients with impaired glucose tolerance and type 2 diabetes.
    Bajraktari G; Koltai MS; Ademaj F; Rexhepaj N; Qirko S; Ndrepepa G; Elezi S
    Int J Cardiol; 2006 Jun; 110(2):206-11. PubMed ID: 16297997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The serum level of soluble CD26/dipeptidyl peptidase 4 increases in response to acute hyperglycemia after an oral glucose load in healthy subjects: association with high-molecular weight adiponectin and hepatic enzymes.
    Aso Y; Terasawa T; Kato K; Jojima T; Suzuki K; Iijima T; Kawagoe Y; Mikami S; Kubota Y; Inukai T; Kasai K
    Transl Res; 2013 Nov; 162(5):309-16. PubMed ID: 23994650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of dipeptidyl peptidase-4 inhibitors in new-onset diabetes after transplantation.
    Lim SW; Jin JZ; Jin L; Jin J; Li C
    Korean J Intern Med; 2015 Nov; 30(6):759-70. PubMed ID: 26552451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New-onset diabetes after liver transplantation and its impact on complications and patient survival.
    Lv C; Zhang Y; Chen X; Huang X; Xue M; Sun Q; Wang T; Liang J; He S; Gao J; Zhou J; Yu M; Fan J; Gao X
    J Diabetes; 2015 Nov; 7(6):881-90. PubMed ID: 25676209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation and diabetes mellitus.
    Steinmüller TH; Stockmann M; Bechstein WO; Settmacher U; Jonas S; Neuhaus P
    Exp Clin Endocrinol Diabetes; 2000; 108(6):401-5. PubMed ID: 11026753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Different prevalence of impaired glucose tolerance between hyperinsulinemic and normoinsulinemic subjects].
    Xiao J; Tian H; Li CL; Zhong WW; Sun BR; Li YP; Fang FS; Han XF; Liu YQ; Cheng XL
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):299-303. PubMed ID: 22781951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.